Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,166,072
+$3,990,747 QoQ
Shares Held
543,165
+3403.8% QoQ
Ownership
0.815%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 168 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 84.74146898272164.ToString("F0")%
Shared 0.ToString("F0")%
None 15.25853101727836.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,242,753 across 213 Biotechnology names. FULC ranks #63 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in FULC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,166,072 | 543,165 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $175,325 | 15,502 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $124,203 | 18,053 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $50,709 | 17,608 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $214,512 | 45,641 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $351,559 | 98,476 | Shares | Other | 2024-11-14 | |
| 2022-06-30 | $68,433 | 13,966 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $248,084 | 14,024 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||